I. Dotan

发表

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

T. Murdoch, M. Silverberg, W. Bemelman, 2015, The American Journal of Gastroenterology.

Carriage of Colibactin-producing Bacteria and Colorectal Cancer Risk.

U. Gophna, I. Dotan, V. Dubinsky, 2020, Trends in microbiology.

Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.

I. Dotan, H. Tulchinsky, D. Roggenbuck, 2013, Journal of Crohn's & colitis.

Endoscopic findings and esophageal cancer incidence among Fanconi Anemia patients participating in an endoscopic surveillance program.

H. Tamary, Y. Goldberg, I. Dotan, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Gut microbiota density influences host physiology and is shaped by host and microbial factors

Judy H. Cho, K. Hao, A. Kasarskis, 2018, bioRxiv.

Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients is Not Rare and Possibly Predictable.

U. Kopylov, S. Ben-Shachar, I. Dotan, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

H. Tilg, S. Vermeire, R. Kiesslich, 2010, Journal of Crohn's & colitis.

Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease: A Population Pharmacokinetic Study

D. Mould, I. Dotan, S. Fishman, 2014, Inflammatory bowel diseases.

AJP- Gastrointestinal and Liver Physiology can be found at: Downloaded from

I. Dotan, L. Mayer, M. Allez, 2006 .

Commensal fungi and their cell‐wall β‐glucans direct differential responses in human intestinal epithelial cells

I. Dotan, K. Rabinowitz, S. Cohen-Kedar, 2020, European journal of immunology.

Human intestinal epithelial cells respond to β‐glucans via Dectin‐1 and Syk

I. Dotan, H. Guzner-Gur, S. Cohen-Kedar, 2014, European journal of immunology.

The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN

M. Gavish, I. Dotan, D. Turner, 2018, Journal of Crohn's & colitis.

B cells engineered to express an anti-HIV antibody allow memory retention, class switch recombination and clonal selection in mice

D. Burstein, Y. Wine, I. Dotan, 2020, bioRxiv.

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.

Z. Halpern, R. T. Altstock, I. Dotan, 2006, Gastroenterology.

Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease.

M. Friger, I. Dotan, S. Regev, 2021, Inflammatory Bowel Diseases.

Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel.

S. Reif, I. Dotan, A. Shitrit, 2013, Journal of Crohn's & colitis.

Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2

R. Sartor, I. Dotan, R. Pawlinski, 2015, Infection and Immunity.

Incidence of Colorectal Adenomas After Bariatric Surgery: Pre-operative Super Morbid Obesity Is Independently Associated with Increased Risk

I. Dotan, Z. Levi, Noam Peleg, 2021, Obesity Surgery.

Establishment of a chemical synthetic lethality screen in cultured human cells.

Y. Oron, I. Dotan, D Canaani, 2001, Genome research.

Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril

R. Kornowski, M. Averbuch, D. Schwartz, 1996, Cardiovascular Drugs and Therapy.

Laboratory Evaluation Including Novel Diagnostic Markers of Inflammatory Bowel Disease

I. Dotan, 2012 .

Comparative analysis of Bayer wide‐range C‐reactive protein (wr‐CRP) and the Dade‐Behring high sensitivity C‐reactive protein (hs‐CRP) in patients with inflammatory bowel disease

Y. Arbel, A. Gal‐Oz, I. Shapira, 2008, Journal of digestive diseases.

Y. Arbel, I. Shapira, S. Berliner, 2006, Digestion.

I. Shapira, S. Berliner, N. Arber, 2005, Digestive Diseases and Sciences.

Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s esophagus

I. Dotan, H. Schmilovitz-Weiss, B. Sapoznikov, 2020, Endoscopy.

Risk of Neoplastic Progression Among Patients with an Irregular Z Line on Long-Term Follow-Up

I. Dotan, Y. Niv, D. Itskoviz, 2018, Digestive Diseases and Sciences.

Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis

C. Hassan, J. Hodson, I. Dotan, 2022, Therapeutic advances in gastroenterology.

Characterization of recombinant murine leukemia virus integrase

P. Brown, I. Dotan, T. Heuer, 1995, Journal of virology.

Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated with Good Maternal and Fetal Outcomes.

D. Rubin, S. Dalal, I. Dotan, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Is stapled ileal pouch anal anastomosis a safe option in ulcerative colitis patients with dysplasia or cancer?

O. Zmora, I. Dotan, O. Zmora, 2009, International Journal of Colorectal Disease.

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease

P. Rutgeerts, D. Hommes, A. Buchman, 2010, Gut.

Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting

S. Ng, C. Lees, C. O'Morain, 2020, Gastroenterology.

Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations

I. Dotan, Subrata Ghosh, E. Louis, 2015, Journal of Crohn's & colitis.

New Serologic Markers for Inflammatory Bowel Disease Diagnosis

I. Dotan, 2010, Digestive Diseases.

Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratification

I. Dotan, 2007, Expert review of gastroenterology & hepatology.

Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial

H. Soreq, I. Dotan, E. Israeli, 2016, Digestive Diseases and Sciences.

Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells.

I. Dotan, L. Mayer, M. Allez, 2002, Gastroenterology.

L-thyroxine prevents the bone-conserving effect of HRT in postmenopausal women with subclinical hypothyroidism.

I. Dotan, A. Pines, Y. Levo, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study

M. Hoshen, R. Balicer, R. Eliakim, 2018, Clinical epidemiology.

Association between polyp detection rate and post colonoscopy cancer among patients undergoing diagnostic colonoscopy.

I. Dotan, A. Flugelman, D. Comaneshter, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.

R. Eliakim, U. Kopylov, B. Weiss, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pediatric-onset Inflammatory Bowel Disease Has Only a Modest Effect on Final Growth: A Report From the epi-IIRN

R. Balicer, I. Dotan, H. Gabay, 2021, Journal of pediatric gastroenterology and nutrition.

In vivo engineered B cells secrete high titers of broadly neutralizing anti-HIV antibodies in mice

S. Tsai, Y. Carmi, D. Nemazee, 2022, Nature Biotechnology.

Inhibition of concanavalin A-induced acute T cell dependent hepatic damage in mice by hypothyroidism.

Z. Halpern, S. Moss, I. Dotan, 1999, Liver.

Liver function in cirrhotic patients in the euthyroid versus the hypothyroid state.

Z. Halpern, I. Dotan, R. Oren, 1998, Journal of clinical gastroenterology.

NOD2 and pouch complications in UC patients: old-world clinical dogmas give way to biological definitions

S. Plevy, I. Dotan, 2013, Gut.

Immunopathogenesis of inflammatory bowel disease

I. Dotan, L. Mayer, 2002, Current opinion in gastroenterology.

34 – NONHEPATIC GASTROINTESTINAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

I. Dotan, L. Mayer, 2004 .

ECM remodelling in IBD: innocent bystander or partner in crime? The emerging role of extracellular molecular events in sustaining intestinal inflammation

I. Dotan, I. Sagi, L. Baram, 2014, Gut.

Fruit consumption is associated with alterations in microbial composition and lower rates of pouchitis.

U. Gophna, I. Dotan, N. Maharshak, 2019, Journal of Crohn's & colitis.

Alterations of Enteric Microbiota in Patients with a Normal Ileal Pouch Are Predictive of Pouchitis

U. Gophna, I. Dotan, N. Maharshak, 2016, Journal of Crohn's & colitis.

Challenges and Opportunities in IBD Clinical Trial Design.

R. Collins, C. O'Morain, M. Silverberg, 2021, Gastroenterology.

Normal Response to Vaccines in Inflammatory Bowel Disease Patients Treated with Thiopurines

Z. Halpern, I. Dotan, L. Mayer, 2012, Inflammatory bowel diseases.

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach

J. Yamamoto-Furusho, L. Peyrin-Biroulet, I. Dotan, 2018, Intestinal research.

Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?

R. Eliakim, U. Kopylov, I. Dotan, 2016, Patient preference and adherence.

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

J. Gisbert, S. Vermeire, A. Hart, 2019, Digestive Diseases.

Properties of latent and thiol-activated rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and regulation of enzyme activity.

I. Dotan, I. Shechter, 1983, Archives of biochemistry and biophysics.

Thiol-disulfide-dependent interconversion of active and latent forms of rat hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

I. Dotan, I. Shechter, 1982, Biochimica et biophysica acta.

Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review

M. Dubinsky, D. Rubin, I. Dotan, 2021, Expert review of gastroenterology & hepatology.

Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study

I. Dotan, D. Comaneshter, A. Cohen, 2018, European journal of gastroenterology & hepatology.

Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery

U. Gophna, I. Dotan, H. Tulchinsky, 2019, European Journal of Nutrition.

Inflammatory Bowel Disease Lamina Propria of Patients with Regulatory T Cells in the + Defects in CD8

I. Dotan, L. Mayer, M. Allez, 2005 .

Increased strength of erythrocyte aggregates in blood of patients with inflammatory bowel disease

Y. Arbel, I. Shapira, S. Berliner, 2009, Inflammatory bowel diseases.

Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment

A. Hart, W. Sandborn, I. Dotan, 2021, Alimentary pharmacology & therapeutics.

Venous Thromboembolism Among Patients With Inflammatory Bowel Diseases is Not Related to Increased Thrombophilia

U. Kopylov, I. Dotan, A. Lubetsky, 2021, Journal of clinical gastroenterology.

Visualizing nuclear RNAi activity in single living human cells

I. Kanter, Y. Shav-Tal, N. Kinor, 2017, Proceedings of the National Academy of Sciences.

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

A. Griffiths, W. Bemelman, D. Rubin, 2020, Gastroenterology.

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic

I. Dotan, I. Amitay-Laish, E. Hodak, 2021, Therapeutic advances in gastroenterology.

Sustained Corticosteroid-Free Clinical Remission During Vedolizumab Maintenance Therapy in Patients with Ulcerative Colitis on Stable Concomitant Corticosteroids During Induction Therapy: A Post Hoc Analysis of GEMINI 1

B. Sands, I. Dotan, E. Loftus, 2020, Clinical and experimental gastroenterology.

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

E. Louis, S. Bonovas, G. Rogler, 2019, United European gastroenterology journal.

Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study.

E. Klang, R. Eliakim, U. Kopylov, 2019, The lancet. Gastroenterology & hepatology.

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX (cid:2) (Cortiment (cid:2) MMX (cid:2) ) for active, mild-to-moderate ulcerative colitis

E. Louis, S. Bonovas, G. Rogler, 2019 .

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study

S. Vermeire, M. Ferrante, U. Kopylov, 2017, Inflammatory bowel diseases.

Safety and effectiveness of ustekinumab for induction of remission in patients with Crohn’s disease: A multicenter Israeli study

U. Kopylov, I. Dotan, B. Koslowsky, 2020, United European gastroenterology journal.

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.

R. Eliakim, U. Kopylov, I. Dotan, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience

R. Eliakim, U. Kopylov, I. Dotan, 2017, Inflammatory bowel diseases.

Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study

U. Kopylov, I. Dotan, A. Shitrit, 2022, Alimentary pharmacology & therapeutics.

Doppler‐guided haemorrhoidal artery ligation in patients with Crohn’s disease

I. Dotan, Y. Skornick, S. Avital, 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Effect of estradiol on rat ileum.

O. Barnea, I. Dotan, A. Pines, 1998, General pharmacology.

Risk of cancer in pediatric-onset inflammatory bowel diseases: A nation-wide study from the epi-IIRN.

R. Balicer, I. Dotan, J. Rowe, 2021, Journal of Crohn's & colitis.

Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and Children

I. Dotan, B. Koslowsky, D. Turner, 2020, Crohn's & colitis 360.

Inflammatory bowel disease serology in Asia and the West.

S. Ng, M. Kamm, I. Dotan, 2013, World journal of gastroenterology.

IBD Around the world: Comparing the epidemiology, diagnosis, and treatment: Proceedings of the World Digestive Health Day 2010 ‐ Inflammatory bowel disease task force meeting

H. Steinhart, M. Vatn, T. Hibi, 2011, Inflammatory bowel diseases.

Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills

I. Dotan, Shlomi Cohen, Y. Ron, 2017, European journal of gastroenterology & hepatology.

Clinical recurrence and re-resection rates after extensive vs. segmental colectomy in Crohn’s colitis: a retrospective cohort study

I. Dotan, H. Tulchinsky, J. Klausner, 2016, Techniques in Coloproctology.

Diet of patients after pouch surgery may affect pouch inflammation.

I. Dotan, N. Vaisman, H. Tulchinsky, 2013, World journal of gastroenterology.

The decline of anti‐drug antibody titres after discontinuation of anti‐TNFs: implications for predicting re‐induction outcome in IBD

U. Kopylov, Y. Mazor, I. Dotan, 2012, Alimentary pharmacology & therapeutics.

The effect of various hormonal preparations and calcium supplementation on bone mass in early menopause. Is there a predictive value for the initial bone density and body weight?

I. Dotan, A. Pines, Y. Levo, 1999, Journal of internal medicine.

IBD Nurse Within the MDT

I. Dotan, R. Barkan, I. Goren, 2019, Inflammatory Bowel Disease Nursing Manual.

Comprehensive pouch clinic concept for follow‐up of patients after ileal pouch anal anastomosis: Report of 3 years' experience in a tertiary referral center

Z. Halpern, I. Dotan, H. Tulchinsky, 2008, Inflammatory bowel diseases.

The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre‐surgical factors

M. Leshno, S. Ben-Shachar, I. Dotan, 2017, Alimentary pharmacology & therapeutics.

The effect of infliximab on extraintestinal manifestations of Crohn’s disease

M. Yaron, I. Dotan, D. Caspi, 2005, Rheumatology International.

Restorative proctocolectomy impairs fertility and pregnancy outcomes in women with ulcerative colitis

Z. Halpern, I. Dotan, H. Tulchinsky, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)

R. Balicer, I. Dotan, H. Gabay, 2022, Journal of pediatric gastroenterology and nutrition.

Perianal Crohn's disease is associated with poor disease outcome: a nation-wide study from the epiIIRN cohort.

R. Balicer, I. Dotan, H. Gabay, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Peripartum Infections Among Women With Inflammatory Bowel Disease.

I. Dotan, E. Hadar, S. Barbash-Hazan, 2022, Inflammatory bowel diseases.

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study

E. Louis, G. Rogler, A. Hart, 2016, BMJ open gastroenterology.

Reply.

I. Dotan, H. Yanai, I. Goren, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

159 Differentiation Between Etrolizumab (Rhumab Beta7) and Placebo in the Eucalyptus Phase II Randomized Double-Blind Placebo-Controlled Induction Study to Evaluate Efficacy and Safety in Patients With Refractory Moderate-to-Severely Active Ulcerative Colitis

J. Mansfield, P. Rutgeerts, S. Vermeire, 2013 .

GUT-SELECTIVE BIOLOGIC THERAPY FOR ULCERATIVE COLITIS: LESSONS FROM SCIENCE AND PRACTICE

J. Lindsay, L. Peyrin-Biroulet, W. Sandborn, 2015 .

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases

N. Freund, I. Dotan, M. Dessau, 2022, Vaccines.

Activation of the superoxide forming NADPH oxidase in a cell-free system by sodium dodecyl sulfate. Absolute lipid dependence of the solubilized enzyme.

A. Abo, I. Dotan, E. Pick, 1989, The Journal of biological chemistry.

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

Stefan Schreiber, Paul Rutgeerts, Adrian Hayday, 2016, Gastroenterology.

Thyroxine accelerates proliferation of injured liver cells.

Z. Halpern, I. Dotan, R. Oren, 1998, Journal of hepatology.

Real‐world multicentre observational study including population pharmacokinetic modelling to evaluate the exposure–response relationship of vedolizumab in inflammatory bowel disease: ERELATE Study

S. Vermeire, W. Sandborn, I. Dotan, 2022, Alimentary pharmacology & therapeutics.

Increasing adherence to the Mediterranean diet and lifestyle is associated with reduced fecal calprotectin and intra-individual changes in microbial composition of healthy subjects

U. Gophna, I. Dotan, K. Rabinowitz, 2022, Gut microbes.

Restorative Proctocolectomy in Elderly IBD Patients: A Multicentre Comparative Study on Safety and Efficacy

W. Bemelman, I. Dotan, Y. Panis, 2016, Journal of Crohn's & colitis.

Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines

S. Vermeire, R. Almog, I. Dotan, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response

J. Gisbert, P. Higgins, A. Hart, 2012, Inflammatory bowel diseases.

CESAME substudy on thiopurines in pregnancy: is this the baby we were waiting for?

I. Dotan, 2012, Inflammatory bowel diseases.

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis

U. Kopylov, Y. Mazor, I. Dotan, 2016, Alimentary pharmacology & therapeutics.

Significance of low level infliximab in the absence of anti-infliximab antibodies.

R. Eliakim, U. Kopylov, I. Dotan, 2015, World journal of gastroenterology.

Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease.

S. Berliner, N. Arber, I. Dotan, 1995, Gut.

Newly Diagnosed Crohn’s Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts

P. Pal, I. Dotan, K. Rabinowitz, 2022, Journal of clinical medicine.

Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease.

Y. Baruch, U. Kopylov, I. Dotan, 2015, Journal of Crohn's & colitis.

Probiotics in inflammatory bowel disease: possible mechanisms of action

I. Dotan, D. Rachmilewitz, 2005, Current opinion in gastroenterology.

Specialized Emergency Department Assessment and Multidisciplinary Intervention After Discharge Improve Management of Patients With Inflammatory Bowel Diseases

I. Dotan, M. Drescher, M. Golan, 2021, Journal of clinical gastroenterology.

Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease

R. Eliakim, U. Kopylov, B. Weiss, 2017, BMC Gastroenterology.

Low-Dose Low-Molecular Weight Heparin (Enoxaparin) Is Effective as Adjuvant Treatment in Active Ulcerative Colitis: An Open Trial

Z. Halpern, N. Arber, I. Dotan, 2001, Digestive Diseases and Sciences.

Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats

N. Arber, I. Dotan, N. Giladi, 2010, Therapeutic advances in gastroenterology.

Chapter 47 – Gastrointestinal: Nonhepatic

I. Dotan, L. Mayer, 2011 .

Idiopathic Pancreatitis Preceding the Diagnosis of Inflammatory Bowel Disease Is More Frequent in Pediatric Patients

B. Weiss, I. Dotan, M. Wilschanski, 2011, Journal of pediatric gastroenterology and nutrition.

Follow-Up of Restorative Proctocolectomy: Clinical Experience of a Specialised Pouch Clinic

Z. Halpern, I. Dotan, H. Tulchinsky, 2006 .

Use of dna amplification methods for clinical diagnosis in autoimmune diseases

I. Dotan, I. Saito, R. Fox, 1989, Journal of clinical laboratory analysis.

European evidenced-based consensus on reproduction in inflammatory bowel disease.

L. Mackillop, S. Vermeire, C. J. van der Woude, 2010, Journal of Crohn's & colitis.

Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouch-anal anastomosis (IPAA).

I. Filip, I. Dotan, A. Eisenthal, 2009, Pathology, research and practice.

Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice

M. Surette, S. Ng, C. Klein, 2021, Nature Genetics.

Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG

B. Oh, Jae U. Jung, I. Dotan, 2006, Nature Cell Biology.

Machine Learning–Based Gene Prioritization Identifies Novel Candidate Risk Genes for Inflammatory Bowel Disease

Ofer Isakov, S. Ben-Shachar, I. Dotan, 2017, Inflammatory bowel diseases.

The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells.

I. Dotan, L. Mayer, M. Allez, 2004, Gastroenterology.

The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti‐integrin therapies

I. Dotan, S. Danese, M. Allez, 2019, Medicinal research reviews.

Activation of a Unique Population of CD8+ T Cells by Intestinal Epithelial Cells

I. Dotan, L. Mayer, M. Allez, 2004, Annals of the New York Academy of Sciences.

Directionality of noncoding human RNAs: how to avoid artifacts.

I. Dotan, D. Canaani, Y. Hachmo, 2013, Analytical biochemistry.

Escherichia coli strains from patients with inflammatory bowel diseases have disease-specific genomic adaptations

U. Gophna, I. Dotan, V. Dubinsky, 2021, bioRxiv.

Gut, inflammation and osteoporosis: basic and clinical concepts

H. Tilg, A. Kaser, A. Moschen, 2008, Gut.

Functional conservation between the human, nematode, and yeast CK2 cell cycle genes.

I. Dotan, C. Glover, D. Canaani, 2001, Biochemical and biophysical research communications.

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

J. Mansfield, P. Rutgeerts, S. Vermeire, 2014, The Lancet.

Results of the 4th scientific workshop of the ECCO (Group II): markers of intestinal fibrosis in inflammatory bowel disease.

P. Higgins, V. Annese, I. Dotan, 2014, Journal of Crohn's & colitis.

Defects in CD8+ Regulatory T Cells in the Lamina Propria of Patients with Inflammatory Bowel Disease 1

Atsushi Nakazawa, Ling Shao, Matthieu Allez, 2005, The Journal of Immunology.

MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes

N. Shomron, S. Ben-Shachar, I. Dotan, 2016, PloS one.

Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch

S. Ben-Shachar, I. Dotan, H. Tulchinsky, 2014, Gut.

Gene Expression Profiles of Ileal Inflammatory Bowel Disease Correlate with Disease Phenotype and Advance Understanding of Its Immunopathogenesis

S. Ben-Shachar, I. Dotan, H. Tulchinsky, 2013, Inflammatory bowel diseases.

Risk factors for chronic pouchitis after ileal pouch–anal anastomosis: a prospective cohort study

Z. Halpern, I. Dotan, H. Tulchinsky, 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Predominantly Antibiotic-resistant Intestinal Microbiome Persists in Patients With Pouchitis Who Respond to Antibiotic Therapy.

U. Gophna, I. Dotan, V. Dubinsky, 2020, Gastroenterology.

Prolonged Antibiotic Treatment Generates a Fluoroquinolone Resistant Gut Microbiome and Collateral Multi-Drug Resistance

U. Gophna, I. Dotan, V. Dubinsky, 2018 .

TITLE: Prolonged Antibiotic Treatment Generates a Fluoroquinolone Resistant Gut Microbiome

U. Gophna, I. Dotan, V. Dubinsky, 2018 .

Strains Colonizing Different Intestinal Sites within an Individual Are Derived from a Single Founder Population

U. Gophna, I. Dotan, V. Dubinsky, 2023, mBio.

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease

I. Dotan, L. Werner, H. Guzner-Gur, 2013, Theranostics.

Genetic synthetic lethality screen at the single gene level in cultured human cells.

Y. Oron, I. Dotan, D. Canaani, 2001, Nucleic acids research.

Inflammatory bowel disease and colorectal cancer: What is new?

I. Dotan, 2009 .

Pouch Care

I. Dotan, R. Barkan, I. Goren, 2019, Inflammatory Bowel Disease Nursing Manual.

B. Weiss, I. Dotan, L. Lichtenstein, 2015, Journal of Crohn's & colitis.

Inhibition of experimentally induced cirrhosis in rats by hypothyroidism

Z. Halpern, I. Dotan, J. Barg, 1996, Hepatology.

SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy

M. Neeman, S. Yagel, I. Dotan, 2022, Vaccines.

Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion

D. Burstein, Y. Wine, Y. Carmi, 2020, Nature Communications.

The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial.

U. Kopylov, I. Dotan, N. Maharshak, 2021, The lancet. Gastroenterology & hepatology.

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.

K. Subramaniam, J. Preiß, I. Dotan, 2015, Journal of Crohn's & colitis.

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD

S. Shen-Orr, Francesco Vallania, P. Khatri, 2018, Gut.

Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies

I. Dotan, S. Fishman, T. Ziv-Baran, 2017, Digestion.

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.

M. Färkkilä, I. Dotan, P. Lakatos, 2011, Journal of Crohn's & colitis.

Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.

U. Gophna, I. Dotan, H. Tulchinsky, 2018, Inflammatory bowel diseases.

Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease

I. Dotan, H. Tulchinsky, L. Yahav, 2015, Inflammatory bowel diseases.

Long-term Antibiotic Treatment in Pouchitis-Patterns of Use and Safety.

U. Gophna, I. Dotan, N. Maharshak, 2021, Inflammatory bowel diseases.

Heparin and low‐molecular‐weight heparin (enoxaparin) significantly ameliorate experimental colitis in rats

Z. Halpern, I. Dotan, D. Rachmilewitz, 2001, Alimentary pharmacology & therapeutics.

Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn’s and ulcerative colitis

O. Zmora, I. Dotan, H. Tulchinsky, 2011, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

A Longitudinal Study of Quality of Life and Functional Outcome of Patients With Ulcerative Colitis After Proctocolectomy With Ileal Pouch-Anal Anastomosis

Z. Halpern, I. Dotan, H. Tulchinsky, 2010, Diseases of the colon and rectum.

Long-term Functional and Quality-of-Life Outcomes After IPAA in Children

I. Dotan, O. Zmora, H. Tulchinsky, 2013, Diseases of the colon and rectum.

Response to Papa et al.

I. Dotan, N. Maharshak, 2008, The American Journal of Gastroenterology.

Sequential capsule endoscopy of the small bowel for follow-up of patients with known Crohn's disease.

I. Dotan, S. Fishman, R. Arnon, 2014, Journal of Crohn's & colitis.

Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.

U. Gophna, I. Dotan, N. Maharshak, 2015, Gastroenterology.

Fecal Calprotectin and Quality of Life Questionnaires Are Responsive to Change in Pouch Disease Activity After Antibiotic Therapy: Results From a Prospective Clinical Trial

I. Dotan, N. Wasserberg, R. Barkan, 2022, The American journal of gastroenterology.

Reply to Antibiotic Use Patterns in the Management of Chronic Pouchitis.

U. Gophna, I. Dotan, V. Dubinsky, 2022, Inflammatory bowel diseases.

Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study from the Porto Group of ESPGHAN.

B. Weiss, I. Dotan, C. Strisciuglio, 2020, Journal of pediatric gastroenterology and nutrition.

Comparing diagnostic yield of a novel pan-enteric video capsule endoscope with ileocolonoscopy in patients with active Crohn's disease: a feasibility study.

J. Leighton, G. Mullin, I. Dotan, 2017, Gastrointestinal endoscopy.

Effect of Previous Nitroimidazole Treatment on Helicobacter pylori Eradication Success

I. Dotan, H. Gabay, S. Birkenfeld, 2020, Journal of clinical gastroenterology.

Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes.

I. Dotan, H. Gabay, Y. Niv, 2019, The American journal of gastroenterology.

Clinical outcomes of endoscopic balloon dilatation of intestinal strictures in patients with Crohn's disease

I. Dotan, N. Maharshak, R. Dekel, 2019, Medicine.

Results of the 2 nd part Scientific Workshop of the ECCO ( II ) : Measures and markers of prediction to achieve , detect , and monitor intestinal healing in Inflammatory Bowel Disease

M. Färkkilä, I. Dotan, P. Lakatos, 2011 .

The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn's Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study.

E. Klang, R. Eliakim, U. Kopylov, 2016, Journal of Crohn's & colitis.

Differential stimulation of peripheral blood mononuclear cells in Crohn's disease by fungal glycans

I. Dotan, H. Guzner-Gur, L. Spektor, 2014, Journal of gastroenterology and hepatology.

Malabsorption is a major contributor to underweight in Crohn's disease patients in remission.

I. Dotan, N. Vaisman, E. Niv, 2006, Nutrition.

Dysbiosis in Metabolic Genes of the Gut Microbiomes of Patients with an Ileo-anal Pouch Resembles That Observed in Crohn's Disease

U. Gophna, I. Dotan, V. Dubinsky, 2020, mSystems.

Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases

U. Kopylov, I. Dotan, R. Shamir, 2022, Therapeutic advances in gastroenterology.

Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN

S. Shen-Orr, Y. Kashi, N. Geva-Zatorsky, 2021, Gut.

S0652 Real World Exposure-Response Relationship of Vedolizumab in Inflammatory Bowel Disease: A Pooled Multicenter Observational Cohort Analysis of Clinical and Modeled Pharmacological Data

S. Vermeire, W. Sandborn, I. Dotan, 2020 .

84 The Effect of Inflammatory Bowel Disease (IBD) During Pregnancy On Long-Term Health and Illness in Children of IBD Patients-a Multicenter Israeli Study

S. Reif, I. Dotan, D. Rachmilewitz, 2009 .

Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.

S. Ben-Shachar, I. Dotan, O. Isakov, 2018, Inflammatory bowel diseases.

Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

C. Lees, U. Kopylov, I. Dotan, 2020, United European gastroenterology journal.

CXCL12 Is a constitutive and inflammatory chemokine in the intestinal immune system

Z. Halpern, I. Dotan, N. Maharshak, 2010, Inflammatory bowel diseases.

COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience

U. Kopylov, Y. Haberman, I. Dotan, 2022, Vaccines.

Molecular cloning of a novel human gene encoding a 63-kDa protein and its sublocalization within the 11q13 locus.

T. Feng, A. Sancar, I. Dotan, 1997, Genomics.

Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease

Z. Halpern, U. Kopylov, I. Dotan, 2011, Journal of leukocyte biology.

Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel.

D. Hovel, U. Kopylov, I. Dotan, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.

A. Ananthakrishnan, J. Reguła, D. Rubin, 2021, The lancet. Gastroenterology & hepatology.

MicroRNA-132 Modulates Cholinergic Signaling and Inflammation in Human Inflammatory Bowel Disease

Z. Halpern, S. Berliner, H. Soreq, 2013, Inflammatory bowel diseases.

In vivo engineered B cells retain memory and secrete high titers of anti-HIV antibodies in mice

S. Tsai, D. Nemazee, I. Dotan, 2021, bioRxiv.

Inflammatory Bowel Disease Is Not Associated With Increased Intimal Media Thickening

Z. Halpern, N. Bornstein, Y. Arbel, 2007, The American Journal of Gastroenterology.

Fecal Proteases from Pouchitis Patients Activate Protease Activating Receptor-2 to Disrupt the Epithelial Barrier.

I. Dotan, I. Carroll, N. Maharshak, 2019, Journal of Crohn's & colitis.

5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study

I. Dotan, H. Yanai, I. Goren, 2023, Alimentary pharmacology & therapeutics.

Clostridium difficile infection in hospitalized patients with inflammatory bowel disease

I. Dotan, N. Maharshak, K. Hod, 2018, Medicine.

Video capsule endoscopy is safe and effective in suspected small bowel bleeding among left ventricular assist device recipients

I. Dotan, T. Ben Gal, D. Itskoviz, 2018, The International journal of artificial organs.

Hypothyroidism inhibits experimentally-induced acute T cell dependent hepatic damage in mice

Z. Halpern, I. Dotan, Z. Matas, 1995 .

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

M. Ferrante, R. Eliakim, U. Kopylov, 2018, Inflammatory bowel diseases.

Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

I. Dotan, F. Konikoff, E. Lansky, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Inverse Relationship Between Clock Gene Expression and Inflammatory Markers in Ulcerative Colitis Patients Undergoing Remission

O. Froy, I. Dotan, N. Chapnik, 2023, Digestive Diseases and Sciences.

Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.

I. Dotan, O. Ledder, E. Matz, 2023, Inflammatory bowel diseases.

Results of the 4 th Scientific Workshop of the ECCO ( Group II ) : Markers of intestinal fibrosis in inflammatory bowel disease tps

V. Annese, I. Dotan, F. Rieder, 2014 .

Of mice and men: a novel dietary supplement for the treatment of ulcerative colitis

N. Arber, I. Dotan, L. Galazan, 2017, Therapeutic advances in gastroenterology.

Microinflammation in patients with Crohn's disease in clinical remission.

Y. Arbel, I. Shapira, S. Berliner, 2008, Journal of Crohn's & colitis.

Clock Gene Disruption is an Initial Manifestation of Inflammatory Bowel Disease.

O. Froy, I. Dotan, N. Chapnik, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Risk of cancer in pediatric-onset inflammatory bowel diseases: A nation-wide study from the epi-IIRN.

R. Balicer, I. Dotan, J. Rowe, 2021, Journal of Crohn's & Colitis.

COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation

I. Dotan, D. Turner, Y. Barak-Corren, 2021, Clinical Gastroenterology and Hepatology.

Selecting Endpoints for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT consensus from the IOIBD.

S. Ng, C. O'Morain, A. Kaser, 2021, Gastroenterology.

Incidence, management and outcomes of very early onset inflammatory bowel diseases and infantile-onset disease: an epi-IIRN study.

G. Kaplan, H. Uhlig, I. Dotan, 2022, Clinical Gastroenterology and Hepatology.

Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

I. Dotan, H. Yanai, 2018, Journal of Crohn's & colitis.

Predictors for poor outcome of hospitalized children with inflammatory bowel disease

I. Dotan, R. Lubetzky, Shlomi Cohen, 2019, European Journal of Pediatrics.

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα

N. Freund, I. Dotan, M. Dessau, 2021, Gastroenterology.

The Modified Mucosal Inflammation Noninvasive Index and Endoscopic Remission in Adults With Crohn's Disease.

S. Vermeire, I. Dotan, D. Turner, 2022, Inflammatory bowel diseases.

Decreased Immune Response to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases Treated with Anti TNFÎ±

N. Freund, I. Dotan, A. Shitrit, 2021, medRxiv.

The association of Inflammatory Bowel Disease with Celiac Disease and Celiac Autoimmunity in children and adults: A nationwide study from the epi-IIRN.

Gavriel David Pinto, I. Dotan, R. Shamir, 2022, Journal of Crohn's & colitis.

Tu1263 Transitional Care in Inflammatory Bowel Disease: A Single Center Experience

I. Dotan, Shlomi Cohen, Y. Ron, 2015 .

Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force

C. O'Morain, G. Kaplan, J. Lindsay, 2020, Journal of Crohn's & colitis.

P122 The clinical and immunological significance of low level of infliximab in the absence of anti-infliximab antibodies in patients with IBD

U. Kopylov, I. Dotan, S. Ben-Horin, 2014 .

93 - Long Term Use of Ciprofloxacin and Metronidazole for Pouchitis – The Low Rate of Adverse Events and the High Association with Antibiotic Resistance

U. Gophna, I. Dotan, N. Maharshak, 2018 .

Exclusive Enteral Nutrition in Adults with Active Crohn's Disease is Associated with Decreased Disease Activity

I. Dotan, N. Maharshak, H. Yanai, 2017 .

Endoscopic Postoperative Recurrence In Crohn's Disease After Curative Ileocecal Resection With Early Prophylaxis By Anti-Tnf, Vedolizumab Or Ustekinumab: A Real-World Multicenter European Study.

J. Gisbert, E. Savarino, K. Farkas, 2022, Journal of Crohn's & colitis.

Association between time to colonoscopy after a positive guaiac fecal test result and risk of colorectal cancer and advanced stage disease at diagnosis

I. Dotan, A. Cohen, Y. Niv, 2020, International journal of cancer.

Pathogenic bacteria on personal handbags of hospital staff.

I. Dotan, S. Malnick, R. Bardenstein, 2009, The Journal of hospital infection.

Alteration in urease-producing bacteria in the gut microbiomes of patients with inflammatory bowel diseases.

U. Gophna, I. Dotan, V. Dubinsky, 2021, Journal of Crohn's & colitis.

Serum Alpha-1 Antitrypsin: A Noninvasive Marker of Pouchitis

I. Dotan, H. Tulchinsky, E. Santo, 2015, Inflammatory bowel diseases.

Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study

U. Kopylov, I. Dotan, A. Shitrit, 2023, Alimentary pharmacology & therapeutics.

Influenza A H1N1 Vaccine is Safe and Effective in Patients With Inflammatory Bowel Disease (IBD) Treated With Thiopurines and TNF-α Blockers

Z. Halpern, I. Dotan, S. Fishman, 2011 .

Increased leukocyte adhesiveness/ aggregation in patients with inflammatory bowel disease during remission

S. Berliner, N. Arber, I. Dotan, 1996, Diseases of the colon and rectum.

Altered thyroid status modulates portal pressure in normal rats.

Z. Halpern, I. Dotan, E. Sikuler, 1999, Liver.

Avoiding food avoidance in patients with inflammatory bowel disease

I. Dotan, L. Godny, 2023, United European gastroenterology journal.

Human intestinal epithelial cells can internalize luminal fungi via LC3-associated phagocytosis

I. Dotan, A. Levy-Barda, N. Wasserberg, 2022, bioRxiv.

Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN.

I. Dotan, R. Shaoul, S. Odes, 2023, Inflammatory bowel diseases.

The risk of advanced neoplasia after polypectomy of one to two non-advanced adenomas less than 5 mm in size vs. normal colonoscopy.

I. Dotan, Z. Levi, M. Golan, 2022, Digestive and Liver Disease.

Optimization of 13C‐urea breath test threshold levels for the detection of Helicobacter pylori infection in a national referral laboratory

I. Dotan, D. Itskoviz, R. Dickman, 2018, Journal of clinical laboratory analysis.

Comparative Effect of Proton-Pump Inhibitors on the Success of Triple and Quadruple Therapy for Helicobacter pylori Infection

I. Dotan, Y. Niv, T. Shochat, 2020, Digestive Diseases.

Improvement in the implementation of Helicobacter pylori management guidelines among primary care physicians following a targeted educational intervention

I. Dotan, S. Birkenfeld, D. Boltin, 2018, Annals of gastroenterology.

ER-Alpha-cDNA As Part of a Bicistronic Transcript Gives Rise to High Frequency, Long Term, Receptor Expressing Cell Clones

J. Hoheisel, I. Dotan, M. Boettcher, 2012, PloS one.

Crohn's Disease Behavior and Location is Altered when Associated with Primary Sclerosing Cholangitis.

I. Dotan, N. Maharshak, O. Shibolet, 2018, The Israel Medical Association journal : IMAJ.

Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn’s disease

E. Klang, U. Kopylov, I. Dotan, 2016, Therapeutic advances in gastroenterology.

M. Leshno, I. Dotan, D. Turner, 2021, Journal of clinical gastroenterology.

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

H. Tilg, A. Gasbarrini, S. Vermeire, 2023, Gut.

P300 Illness perceptions and coping with health-related quality of life in patients with inflammatory bowel disease.

Y. Benyamini, I. Dotan, H. Tulchinsky, 2017, Journal of Crohn's & colitis.

OP12 Does early initiation of biologics change the natural history of IBD? a nationwide study from the epi-IIRN

I. Dotan, E. Matz, N. Lederman, 2023, Journal of Crohn's & Colitis.

Young GI Angle: What makes for a good mentor?

I. Dotan, J. Burisch, 2016, United European gastroenterology journal.

Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery.

S. Ben-Shachar, I. Dotan, K. Rabinowitz, 2018, Inflammatory bowel diseases.

Machine learning for selecting patients with Crohn's disease for abdominopelvic computed tomography in the emergency department.

I. Dotan, H. Yanai, I. Goren, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey.

D. Rubin, L. Peyrin-Biroulet, I. Dotan, 2022, The lancet. Gastroenterology & hepatology.

Correlation between Quantitative 13C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort

I. Dotan, R. Dickman, Z. Levi, 2018, Gastroenterology research and practice.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

H. Tilg, A. Forbes, C. O'Morain, 2010, Journal of Crohn's & colitis.

Disease Behavior in Adult Patients: Are There Predictors for Stricture or Fistula Formation?

I. Dotan, 2009, Digestive Diseases.

Role of CD24 Polymorphisms in the Susceptibility to Inflammatory Bowel Disease

Moshe Leshno, Nadir Arber, M. Leshno, 2014, The International journal of biological markers.

S818 An Insight into the Patient’s Perspective of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts: Key Triggers and Symptoms of Flares

B. Sands, I. Dotan, I. Modesto, 2022, American Journal of Gastroenterology.

Identification of a novel metastasis inducing lncRNA which suppresses the KAI1/CD82 metastasis suppressor gene and is upregulated in triple-negative breast cancer.

A. Hotz-Wagenblatt, I. Dotan, D. Canaani, 2017, Oncotarget.

P210 The associations of optimism, social support, and coping strategies with health-related quality of life in a cohort of patients after proctocolectomy with ileal Pouch-anal anastomosis.

Y. Benyamini, I. Dotan, H. Tulchinsky, 2017, Journal of Crohn's & colitis.

Video Capsule Endoscopy after Bariatric Surgery: A Tertiary Referral Center Experience

I. Dotan, H. Yanai, Rachel Gingold-Belfer, 2022, Digestive Diseases.

Subject Index Vol. 73, 2006

J. Mate, J. Gisbert, E. Savarino, 2006, Digestion.

Clostridium difficile infection in hospitalized patients with inflammatory bowel disease

I. Dotan, N. Maharshak, K. Hod, 2018, Medicine.

Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.

C. O'Morain, A. Griffiths, L. Peyrin-Biroulet, 2023, The lancet. Gastroenterology & hepatology.

P689 Biologics utilization in children with inflammatory bowel diseases is higher and earlier than in adults: a report from the epi-IIRN group.

M. Gavish, I. Dotan, E. Benchimol, 2017, Journal of Crohn's & Colitis.

Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)

G. Kaplan, C. Bernstein, R. Gearry, 2023, BMC Medical Research Methodology.

Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data

I. Dotan, H. Yanai, H. Banai, 2023, Journal of Clinical Medicine.

Endoscopic Assessment of the Pouch: An Essential Step Forward.

I. Dotan, J. Ollech, 2021, Journal of Crohn's & colitis.

P506 Increased risk of anti-drug antibodies to a second anti-TNF in patients who developed antibodies to the first anti-TNF

I. Dotan, R. Shamir, S. Amir, 2020 .

Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases

I. Dotan, L. Lichtenstein, A. Levy-Barda, 2023, Vaccines.

Decoding pooled RNAi screens by means of barcode tiling arrays

J. Hoheisel, A. Gholami, I. Dotan, 2010, BMC Genomics.

Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel.

S. Reif, I. Dotan, A. Shitrit, 2013, Journal of Crohn's & Colitis.

Faculty Opinions recommendation of Lower Serologic Response to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases Treated with Anti-TNFα.

N. Freund, I. Dotan, M. Dessau, 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial

H. Soreq, I. Dotan, E. Israeli, 2016, Digestive Diseases and Sciences.

CXCL12 Is a constitutive and inflammatory chemokine in the intestinal immune system

Z. Halpern, I. Dotan, N. Maharshak, 2010, Inflammatory bowel diseases.

Commitment and rival attractiveness: Their effects on male and female reactions to jealousy-arousing situations

I. Dotan, A. Nadler, 1992 .

The decline of anti‐drug antibody titres after discontinuation of anti‐TNFs: implications for predicting re‐induction outcome in IBD

U. Kopylov, Y. Mazor, I. Dotan, 2012, Alimentary pharmacology & therapeutics.

A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes

I. Dotan, K. Rabinowitz, R. Barkan, 2023, Crohn's & colitis 360.

Patency Capsule: A Novel Independent Predictor for Long-Term Outcomes Among Patients With Quiescent Crohn's Disease

U. Kopylov, I. Dotan, S. Ben-Horin, 2022, The American journal of gastroenterology.

Magnetic resonance enterography versus capsule endoscopy activity indices for quantification of small bowel inflammation in Crohn’s disease

E. Klang, U. Kopylov, I. Dotan, 2016, Therapeutic advances in gastroenterology.

Falk Symposium Series

Claudio Fiocchi, Peter L. Lakatos, Ashwin N. Ananthakrishnan, 2009, Digestive Diseases.

P683 Patients with newly diagnosed fistulizing perianal Crohn’s disease have a distinct microbial signature

I. Dotan, L. Reshef, M. Pauker, 2021 .

Gut Microbiome Composition is associated with future onset of Crohn's Disease in Healthy First-Degree Relatives.

P. Moayyedi, M. Silverberg, A. Griffiths, 2023, Gastroenterology.

Association Between Response to Etrolizumab and Expression of Integrin αE and Granzyme A in Colon Biopsies of Patients With Ulcerative Colitis.

J. Mansfield, P. Rutgeerts, S. Vermeire, 2016, Gastroenterology.

P412 Drug persistence and endoscopic, histologic and biochemical remission rates among patients following ileal pouch-anal anastomosis treated with biologic therapy: Results from a prospective patient cohort

I. Dotan, N. Wasserberg, H. Yanai, 2022, Journal of Crohn's and Colitis.

Fecal calprotectin is increased in pouchitis and progressively increases with more severe endoscopic and histologic disease.

I. Dotan, N. Maharshak, H. Tulchinsky, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats

N. Arber, I. Dotan, N. Giladi, 2010, Therapeutic advances in gastroenterology.